ENDRA LIFE SCIENCES INC. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
ENDRA LIFE SCIENCES INC. (NDRA) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 3.27 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-14
- ENDRA LIFE SCIENCES INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-06-30 was 3.27M shares, a 855.03% increase year-over-year.
- ENDRA LIFE SCIENCES INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 2.98M shares, a 1548.96% increase year-over-year.
- ENDRA LIFE SCIENCES INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-06-30 was 342.50K shares.
- ENDRA LIFE SCIENCES INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-03-31 was 180.98K shares, a 87.47% decline year-over-year.
- ENDRA LIFE SCIENCES INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 180.99K shares, a 22867.77% increase from fiscal 2023.
- ENDRA LIFE SCIENCES INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 788.00 shares, a 99.81% decline from fiscal 2022.
- ENDRA LIFE SCIENCES INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 410.36K shares, a 4.57% increase from fiscal 2021.
- ENDRA LIFE SCIENCES INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2021 was 392.43K shares, a 96.09% decline from fiscal 2020.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-06-30 | 3.27M shares 10-Q · filed 2026-08-14 | 4.58M shares 10-Q · filed 2026-08-14 | ||||
| 2026-03-31 | 2.98M shares 10-Q · filed 2026-05-15 | |||||
| 2025-12-31 | 2.63M shares 10-Q · filed 2026-05-15 | |||||
| 2025-09-30 | 328.14K shares 10-Q · filed 2025-11-14 | |||||
| 2025-06-30 | 342.50K shares 10-Q · filed 2026-08-14 | 342.50K shares 10-Q · filed 2026-08-14 | ||||
| 2025-03-31 | 180.98K shares 10-Q · filed 2025-05-15 | |||||
| 2024-12-31 | 180.99K shares 10-K · filed 2026-03-31 | 1.51M shares 10-K · filed 2024-03-28 | ||||
| 2024-09-30 | 181.97K shares 10-Q/A · filed 2024-11-21 | |||||
| 2024-06-30 | 4.52M shares 10-Q · filed 2024-08-14 | |||||
| 2024-03-31 | 1.44M shares 10-Q · filed 2024-05-14 | |||||
| 2023-12-31 | 788.00 shares 10-K/A · filed 2025-04-07 | 1.51M shares 10-K · filed 2024-03-28 | ||||
| 2023-09-30 | 3.10M shares 10-Q · filed 2023-11-14 | |||||
| 2023-06-30 | 3.12M shares 10-Q · filed 2023-08-14 | |||||
| 2023-03-31 | 665.10K shares 10-Q · filed 2023-05-15 | |||||
| 2022-12-31 | 410.36K shares 10-K · filed 2024-03-28 | |||||
| 2022-09-30 | 8.38M shares 10-Q · filed 2022-11-14 | 8.38M shares 10-Q · filed 2022-11-14 | ||||
| 2022-06-30 | 8.51M shares 10-Q · filed 2022-08-15 | |||||
| 2022-03-31 | 410.36K shares 10-Q · filed 2023-05-15 | 10.56M shares 10-Q · filed 2022-05-12 | ||||
| 2021-12-31 | 392.43K shares 10-K · filed 2023-03-16 | 7.85M shares 10-K · filed 2022-03-30 | ||||
| 2021-09-30 | 7.70M shares 10-Q · filed 2021-11-15 | |||||
| 2021-06-30 | 7.67M shares 10-Q · filed 2021-08-12 | |||||
| 2021-03-31 | 6.58M shares 10-Q · filed 2021-05-17 | |||||
| 2020-12-31 | 10.05M shares 10-K · filed 2022-03-30 | |||||
| 2020-09-30 | 9.91M shares 10-Q · filed 2020-11-16 | |||||
| 2020-06-30 | 17.93M shares 10-Q · filed 2020-08-14 | |||||
| 2020-03-31 | 19.99M shares 10-Q · filed 2020-05-14 | |||||
| 2019-12-31 | 24.95M shares 10-K · filed 2021-03-25 | |||||
| 2019-09-30 | 7.68M shares 10-Q · filed 2019-11-13 | |||||
| 2019-06-30 | 4.17M shares 10-Q · filed 2019-08-08 | |||||
| 2019-03-31 | 4.07M shares 10-Q · filed 2019-05-14 | |||||
| 2018-12-31 | 3.90M shares 10-K · filed 2020-03-26 | |||||
| 2018-09-30 | 3.24M shares 10-Q · filed 2018-11-05 | |||||
| 2018-06-30 | 3.27M shares 10-Q · filed 2018-08-13 | |||||
| 2018-03-31 | 3.27M shares 10-Q · filed 2018-05-15 | |||||
| 2017-12-31 | 3.21M shares 10-K · filed 2019-03-11 | |||||
| 2017-09-30 | 3.19M shares 10-Q · filed 2017-11-14 | |||||
| 2017-06-30 | 3.18M shares 10-Q · filed 2017-08-07 | |||||
| 2017-03-31 | 1.53M shares 10-Q · filed 2017-06-21 | |||||
| 2016-12-31 | 1.35M shares 10-K · filed 2018-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IRIDEX CORP (IRIX) | United States | $0.011B | |
| Nuwellis, Inc. (NUWE) | United States | $0.003B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B |